Introduction: Intravenous immune globulin 10% liquid (IVIG 10%) is used in the treatment of primary immunodeficiency (PID). Originally approved in 2012 and then voluntarily withdrawn in 2016, IVIG 10% ...

AOM Infusion ("AOM"), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U ...

Doctors diagnosed Minnesota high school student Luke Wachowiak with dermatomyositis and rheumatoid arthritis in 2022. Since then, he's had to receive monthly five-hour IVIG infusions to fight the ...

The MarketWatch News Department was not involved in the creation of this content. TEANECK, N.J., July 16, 2025 /PRNewswire/ -- GC Biopharma USA, Inc., a leader in plasma-derived products, announced ...

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.

Transitioning to lifelong IVIG infusions was challenging, requiring acceptance of a new normal and frequent treatments. Angela, a compassionate nurse, significantly improved the patient's experience ...